Recent research shows that GLP-1 medications help lowerinflammation, leading to fewer flares, less joint pain and stiffness, better movement, and more energy
Over time, GeneDx plans to expand into newborn screening, a potentially $10 billion marketthen eventually into adult screening to replace multi-gene panel and individual gene tests, a future market pegged at $16 billion, Katherine Stueland, GeneDxs president and CEO, told GEN Edge last month With tougher comps in 25 and a potential headwind to revenues emerging in HCT, it is harder to argue for multiple expansion from here, Peterson said
Late escalation (weeks 1316, 1.7 mg): approaching the therapeutic window used in the weight-management trials
Cellular Repair: It plays a role in repairing damaged cells and promoting healthy cell function